Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

Low-grade B-cell lymphomas other than follicular and small lymphocytic lymphoma (LGBCL) account for 10% of all B-cell non-Hodgkin lymphomas. Despite improvements in survival outcomes for these patients, little is known about cause of death (COD) in the rituximab era. For a better understanding, we s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tun, Aung M., Khurana, Arushi, Mwangi, Raphael, Link, Brian K., Wang, Yucai, Feldman, Andrew L., Thompson, Carrie A., Novak, Anne J., Villasboas, Jose C., Thanarajasingam, Gita, Farooq, Umar, Syrbu, Sergei, Nowakowski, Grzegorz S., Witzig, Thomas E., Ansell, Stephen M., Rimsza, Lisa M., Cerhan, James R., Habermann, Thomas M., Maurer, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631639/
https://www.ncbi.nlm.nih.gov/pubmed/35849723
http://dx.doi.org/10.1182/bloodadvances.2022007990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631639/
https://www.ncbi.nlm.nih.gov/pubmed/35849723
http://dx.doi.org/10.1182/bloodadvances.2022007990

Ejemplares similares